In this study, we explored the epigenetic regulation of MYO1G gene expression through the DNA methylation in the promoter region and evaluated the MYO1G promoter methylation and gene expression as biomarkers associated with immunotherapy response, overall survival, progression free survival and immune cell infiltration in melanoma. The gene discussed is MYO1G; the disease is melanoma.